See up to 3 months of SRZN. The 7-day demo opens the 1M and 3M ranges and puts SRZN on your watchlist.
Start 7-day demoLatest SRZN insider trades
About Surrozen, Inc./DE (SRZN)
Surrozen, Inc./DE files with the SEC under CIK 0001824893 and is classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
SRZN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 325,000 | $6.91M |
SRZN insider transactions (Form 4)
7441 Form 4 filings on record, the earliest from May 14, 2025, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| TCG Crossover GP II, LLC | Open-market sale | Common Stock | 162,500 | $21.25 | $3.45M | |
| TCG Crossover GP II, LLC | Open-market sale | Common Stock | 162,500 | $21.25 | $3.45M | |
| Andrew Pedrum Maleki - Officer | Grant or award | Common Stock | 607 | $19.01 | $12K | |
| Yang Li - Officer | Grant or award | Common Stock | 1,666 | $8.11 | $14K | |
| Charles O. Williams - Officer | Grant or award | Common Stock | 1,666 | $8.11 | $14K | |
| Craig C. Parker - Officer | Grant or award | Common Stock | 1,622 | $8.11 | $13K | |
 Tim Kutzkey | Grant or award | Option (right to buy) | 5,550 | $0.00 | - | |
| Mace Rothenberg | Grant or award | Director Stock Option (right to buy) | 5,550 | $0.00 | - | |
| David J. Woodhouse | Grant or award | Director Stock Option (right to buy) | 5,550 | $0.00 | - | |
 Mary Haak-Frendscho | Grant or award | Director Stock Option (right to buy) | 5,550 | $0.00 | - | |
 Christopher Y. Chai | Grant or award | Director Stock Option (right to buy) | 5,550 | $0.00 | - | |
 Eric Bjerkholt | Grant or award | Director Stock Option (right to buy) | 5,550 | $0.00 | - | |
 Anna Berkenblit | Grant or award | Director Stock Option (right to buy) | 5,550 | $0.00 | - | |
| Yang Li - Officer | Option exercise | Common Stock | 4,375 | - footnote F1 | - | |
| Yang Li - Officer | Open-market sale | Common Stock | 1,584 | $33.33 footnote F2 | $53K | |
| Yang Li - Officer | Option exercise | Restricted Stock Unit | 4,375 | $0.00 | - | |
| ||||||
| Charles O. Williams - Officer | Option exercise | Common Stock | 5,625 | - footnote F1 | - | |
| Charles O. Williams - Officer | Open-market sale | Common Stock | 2,036 | $33.33 footnote F2 | $68K | |
| Charles O. Williams - Officer | Option exercise | Restricted Stock Unit | 5,625 | $0.00 | - | |
| ||||||
| Craig C. Parker - Officer | Option exercise | Common Stock | 12,500 | - footnote F1 | - | |
| Craig C. Parker - Officer | Open-market sale | Common Stock | 4,524 | $33.33 footnote F2 | $151K | |
| Craig C. Parker - Officer | Option exercise | Restricted Stock Unit | 12,500 | $0.00 | - | |
| ||||||
| Yang Li - Officer | Gift | Common Stock | 1,666 | $0.00 | - | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 7,612 | $24.90 | $190K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 7,611 | $24.90 | $190K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 53,329 | $24.69 | $1.32M | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 53,329 | $24.69 | $1.32M | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 6,187 | $24.99 | $155K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 6,187 | $24.99 | $155K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 17,717 | $24.88 | $441K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 17,716 | $24.88 | $441K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 595 | $24.99 | $15K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 595 | $24.99 | $15K | |
| Yang Li - Officer | Grant or award | Employee Stock Option (right to buy) | 100,950 | $0.00 | - | |
| Yang Li - Officer | Grant or award | Restricted Stock Unit | 100,950 | $0.00 | - | |
| Charles O. Williams - Officer | Grant or award | Employee Stock Option (right to buy) | 102,900 | $0.00 | - | |
| Charles O. Williams - Officer | Grant or award | Restricted Stock Unit | 102,900 | $0.00 | - | |
| Craig C. Parker - Officer | Grant or award | Employee Stock Option (right to buy) | 242,200 | $0.00 | - | |
| Craig C. Parker - Officer | Grant or award | Restricted Stock Unit | 242,200 | $0.00 | - | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 8,882 | $23.58 | $209K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 8,881 | $23.58 | $209K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 547 | $23.86 | $13K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 546 | $23.86 | $13K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 2,136 | $21.39 | $46K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 2,135 | $21.39 | $46K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 366 | $21.38 | $8K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 365 | $21.38 | $8K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 2,178 | $21.94 | $48K | |
| TCG Crossover GP II, LLC | Open-market purchase | Common Stock | 2,177 | $21.94 | $48K | |
| Charles O. Williams - Officer | Grant or award | Employee Stock Option (right to buy) | 500 | $0.00 | - | |
| COLUMN GROUP III GP, LP | Open-market purchase | Common Stock | 5,590 | $19.89 | $111K | |
| COLUMN GROUP III GP, LP | Open-market purchase | Common Stock | 6,303 | $19.89 | $125K | |
| COLUMN GROUP III GP, LP | Open-market purchase | Common Stock | 1,204 | $20.00 | $24K | |
| COLUMN GROUP III GP, LP | Open-market purchase | Common Stock | 1,358 | $20.00 | $27K | |
| COLUMN GROUP III GP, LP | Open-market purchase | Common Stock | 8,484 | $19.60 | $166K | |
| COLUMN GROUP III GP, LP | Open-market purchase | Common Stock | 9,568 | $19.60 | $188K | |
| Tim Kutzkey | Open-market purchase | Common Stock | 5,590 | $19.89 | $111K | |
| Tim Kutzkey | Open-market purchase | Common Stock | 6,303 | $19.89 | $125K | |
| Tim Kutzkey | Open-market purchase | Common Stock | 1,204 | $20.00 | $24K | |
| Tim Kutzkey | Open-market purchase | Common Stock | 1,358 | $20.00 | $27K | |
| Tim Kutzkey | Open-market purchase | Common Stock | 8,484 | $19.60 | $166K | |
| Tim Kutzkey | Open-market purchase | Common Stock | 9,568 | $19.60 | $188K | |
| Tim Kutzkey | Open-market purchase | Common Stock | 5,861 | $19.80 | $116K | |
| Tim Kutzkey | Open-market purchase | Common Stock | 6,609 | $19.80 | $131K | |
| Tim Kutzkey | Open-market purchase | Common Stock | 2,596 | $19.99 | $52K | |
| Tim Kutzkey | Open-market purchase | Common Stock | 2,927 | $19.99 | $59K | |
| COLUMN GROUP III GP, LP | Open-market purchase | Common Stock | 5,861 | $19.80 | $116K | |
| COLUMN GROUP III GP, LP | Open-market purchase | Common Stock | 6,609 | $19.80 | $131K | |
| COLUMN GROUP III GP, LP | Open-market purchase | Common Stock | 2,596 | $19.99 | $52K | |
| COLUMN GROUP III GP, LP | Open-market purchase | Common Stock | 2,927 | $19.99 | $59K | |
| COLUMN GROUP III GP, LP | Open-market purchase | Common Stock | 7,097 | $19.89 | $141K | |
| COLUMN GROUP III GP, LP | Open-market purchase | Common Stock | 8,003 | $19.89 | $159K | |
| Tim Kutzkey | Open-market purchase | Common Stock | 7,097 | $19.89 | $141K | |
| Tim Kutzkey | Open-market purchase | Common Stock | 8,003 | $19.89 | $159K | |
Item 8.01
Item 2.02
Item 5.07
Item 2.02, 9.01
SRZN insider trading FAQ
What is the latest insider trade for SRZN?
Surrozen, Inc./DE (SRZN) had 1 insider filing in the last 90 days, with the most recent on 2026-07-25. The full record for SRZN runs to 41 Form 4 filings, the earliest from 2025-05-14. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SRZN stock?
No insider purchases of SRZN were filed in the last 90 days. 56 purchases are on record for this company.
How many insiders are selling SRZN stock?
2 insider sales of SRZN were filed in the last 90 days, totaling $6.91M.
Where can I see SRZN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SRZN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - TCG Crossover GP II, LLC view on EDGAR
- - Andrew Pedrum Maleki view on EDGAR
- - Yang Li view on EDGAR
- - Charles O. Williams view on EDGAR
- - Craig C. Parker view on EDGAR
- - Tim Kutzkey view on EDGAR
- - Mace Rothenberg view on EDGAR
- - David J. Woodhouse view on EDGAR
- - Mary Haak-Frendscho view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Insider activity in Health Care
- Where SRZN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SRZN with a 7-day demo
- SRZN on your watchlist
- Every SRZN Form 4 filing on record
- Up to 3 months of SRZN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
